Cosmos Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cosmos Health Inc.
- Former names
- Cosmos Holdings Inc. Prime Estates & Developments Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 5122 — Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Thessaloniki
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- COSM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001474167
- EIN
- 27-0611758
Board of directors
-
Anastasios Aslidis · DirectorSince 2023
-
Demetrios G. Demetriades · Director · SecretarySince 2024
-
Grigorios Siokas · Director · Chief Executive OfficerSince 2023
-
John James Hoidas · DirectorSince 2023
-
Manfred Ziegler · DirectorSince 2022
-
Suhel Bhutawala · DirectorSince 2023
-
Theodoros Christos Karkantzos · DirectorSince 2026
Chief executives
Grigorios Siokas
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of July 15, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.1%
-
81.0%
-
81.0%
-
82.5%
-
83.4%
-
84.2%
Board connections
1 of this board's directors also sit on 2 other boards.
- via Anastasios Aslidis
- via Anastasios Aslidis
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,749,406
- 21 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 30, 2026 | Grigorios Siokas Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +349,825 | $0.20 | $70,000 |
| Jul 29, 2026 | Grigorios Siokas Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +766,284 | $0.18 | $140,000 |
| Jul 29, 2026 | Terzis Georgios Officer (Chief Financial Officer) | Grant or award | +328,407 | $0.18 | $60,000 |
| Jun 16, 2026 | Terzis Georgios Officer (Chief Financial Officer) | Open-market purchase | +168,135 | $0.25 | $42,034 |
| Jun 11, 2026 | Grigorios Siokas Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +218,447 | $0.21 | $45,874 |
| Jun 10, 2026 | Grigorios Siokas Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +701,447 | $0.23 | $161,333 |
| May 19, 2026 | Theodoros Christos Karkantzos Director | Grant or award | +20,000 | $0.28 | $5,600 |
| May 19, 2026 | John James Hoidas Director | Grant or award | +20,000 | $0.28 | $5,600 |
| May 19, 2026 | Demetrios G. Demetriades Director, Officer (Secretary) | Grant or award | +20,000 | $0.28 | $5,600 |
| May 19, 2026 | Anastasios Aslidis Director | Grant or award | +40,000 | $0.28 | $11,200 |
| May 19, 2026 | Suhel Bhutawala Director | Grant or award | +20,000 | $0.28 | $5,600 |
| May 19, 2026 | Terzis Georgios Officer (Chief Financial Officer) | Grant or award | +850,000 | $0.28 | $238,000 |
| May 19, 2026 | Grigorios Siokas Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +2,350,000 | $0.28 | $658,000 |
| Feb 12, 2026 | Grigorios Siokas Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +388,532 | $0.37 | $143,757 |
| Feb 11, 2026 | Grigorios Siokas Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +291,262 | $0.41 | $119,417 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.